FDA Inspection 1323352 — Paul S. Bradley, MD
The FDA completed an inspection of Paul S. Bradley, MD on June 11, 2026 in Savannah, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 11, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Savannah, GA (United States)
Additional Details
Clinical Investigator (CI)